세계의 동물용 바이오마커 시장 규모 조사 및 예측 : 동물 유형별, 제품 유형별, 용도별, 질병 유형별, 지역별 분석(2023-2030년)

Global Veterinary Biomarkers Market is valued at approximately USD 0.79 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 12.61% over the forecast period 2023-2030. Veterinary biomarkers refer to measurable indicators or substances present in animals' biological samples, such as blood, urine, or tissues, that is used to detect, diagnose, monitor, or predict veterinary diseases or conditions. These biomarkers include proteins, enzymes, hormones, genetic markers, metabolites, or other molecules that exhibit specific changes in response to physiological, pathological, or pharmacological processes. Additionally, the rising incidence of chronic diseases such as cancer and cardiovascular conditions in animals, coupled with the expanding population of companion animals, is a significant driver for the demand for veterinary biomarker.

The veterinary biomarkers market is driven by the expansion of product offerings, higher expenditure on animal healthcare, and increased pet adoption in emerging nations. the American Pet Products Association's 2023 report stated thatin the United States, the pet industry expenditure increased from USD 90.5 billion in 2018 to USD 136.8 billion in 2022, with a projected further increase to USD 143.6 billion by the end of 2023. Similarly, according to FEDIAF in 2020, in Europe, substantial spending on pet-related services and products, totaled for 21.2 billion. Moreover, growth in the veterinary biomarkers market is being fueled by R&D efforts undertaken by major companies to enhance their biomarker portfolios. Furthermore, the increasing rates of pet adoption are serving as additional factors that contribute to the market's growth. However, the high cost associated with biomarker development and commercialization and the limited availability of standardized biomarker assays stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Veterinary Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the significant adoption of companion animals and substantial annual expenditure on pet care. The increasing presence of licensed and trained veterinarians in countries, along with the growing number of veterinary clinics, serves as another catalyst for the market's growth. Asia Pacific is expected to fastest growing during the forecast period, this growth is attributed to factors such as increased animal healthcare expenditure, rising disposable income in key markets, and growing awareness of biomarkers in veterinary practices. The growing demand for accurate and timely disease diagnosis, as well as the trend of pet humanization in developing countries such as India, are the further factors that are contributing to the regional market's expansion.

Major market players included in this report are:

• Zoetis Services LLC
• Virbac
• Veterinary Biomarkers, Inc.
• ACUVET BIOTECH
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• MI:RNA Diagnostics Ltd
• Mercodia AB
• Antech Diagnostics, Inc.
• Vimian Group

Recent Developments in the Market:

• In June 2023, IDEXX Laboratories, Inc., a renowned innovator in pet healthcare, recently introduced the world's first veterinary diagnostic test designed specifically for detecting kidney injury in both cats and dogs.
• In February 2022, VMRD, Inc., a leading developer and manufacturer of veterinary diagnostic test kits and reagents, recently expanded its molecular product line by introducing nucleic acid extraction kits for gene sequencing and gene expression studies in animals. This kit enables rapid and efficient preparation of highly pure viral nucleic acids from various sample types such as tissue homogenates, swabs, serum, and plasma.

Global Veterinary Biomarkers Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Animal Type, Product Type, Application, Disease Type, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Animal Type:

• Companion Animals
• Production Animals

By Product Type:

• Biomarkers, Kits & Reagents
• Biomarker Readers

By Application:

• Disease Diagnostics
• Preclinical Research
• Others

By Disease Type:

• Inflammatory & Infectious Diseases
• Cardiovascular Diseases
• Skeletal Muscle Diseases
• Tumor
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Veterinary Biomarkers Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Veterinary Biomarkers Market, by Animal Type, 2020-2030 (USD Billion)
  • 1.2.3. Veterinary Biomarkers Market, by Product Type, 2020-2030 (USD Billion)
  • 1.2.4. Veterinary Biomarkers Market, by Application, 2020-2030 (USD Billion)
  • 1.2.5. Veterinary Biomarkers Market, by Disease Type, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Veterinary Biomarkers Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Veterinary Biomarkers Market Dynamics

• 3.1. Veterinary Biomarkers Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of chronic diseases in animals
    • 3.1.1.2. Growing population of companion animals
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost of veterinary biomarkers development
    • 3.1.2.2. Limited availability of standardized biomarker assays
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing R&D activities undertaken by major companies
    • 3.1.3.2. Increasing rates of pet adoption

Chapter 4. Global Veterinary Biomarkers Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Veterinary Biomarkers Market, by Animal Type

• 5.1. Market Snapshot
• 5.2. Global Veterinary Biomarkers Market by Animal Type, Performance - Potential Analysis
• 5.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Animal Type 2020-2030 (USD Billion)
• 5.4. Veterinary Biomarkers Market, Sub Segment Analysis
  • 5.4.1. Companion Animals
  • 5.4.2. Production Animals

Chapter 6. Global Veterinary Biomarkers Market, by Product Type

• 6.1. Market Snapshot
• 6.2. Global Veterinary Biomarkers Market by Product Type, Performance - Potential Analysis
• 6.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
• 6.4. Veterinary Biomarkers Market, Sub Segment Analysis
  • 6.4.1. Biomarkers, Kits & Reagents
  • 6.4.2. Biomarker Readers

Chapter 7. Global Veterinary Biomarkers Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Veterinary Biomarkers Market by Application, Performance - Potential Analysis
• 7.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Veterinary Biomarkers Market, Sub Segment Analysis
  • 7.4.1. Disease Diagnostics
  • 7.4.2. Preclinical Research
  • 7.4.3. Others

Chapter 8. Global Veterinary Biomarkers Market, by Disease Type

• 8.1. Market Snapshot
• 8.2. Global Veterinary Biomarkers Market by Disease Type, Performance - Potential Analysis
• 8.3. Global Veterinary Biomarkers Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
• 8.4. Veterinary Biomarkers Market, Sub Segment Analysis
  • 8.4.1. Inflammatory & Infectious Diseases
  • 8.4.2. Cardiovascular Diseases
  • 8.4.3. Skeletal Muscle Diseases
  • 8.4.4. Tumor
  • 8.4.5. Others

Chapter 9. Global Veterinary Biomarkers Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Veterinary Biomarkers Market, Regional Market Snapshot
• 9.4. North America Veterinary Biomarkers Market
  • 9.4.1. U.S. Veterinary Biomarkers Market
    • 9.4.1.1. Animal Type breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Product Type breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. Disease Type breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Veterinary Biomarkers Market
• 9.5. Europe Veterinary Biomarkers Market Snapshot
  • 9.5.1. U.K. Veterinary Biomarkers Market
  • 9.5.2. Germany Veterinary Biomarkers Market
  • 9.5.3. France Veterinary Biomarkers Market
  • 9.5.4. Spain Veterinary Biomarkers Market
  • 9.5.5. Italy Veterinary Biomarkers Market
  • 9.5.6. Rest of Europe Veterinary Biomarkers Market
• 9.6. Asia-Pacific Veterinary Biomarkers Market Snapshot
  • 9.6.1. China Veterinary Biomarkers Market
  • 9.6.2. India Veterinary Biomarkers Market
  • 9.6.3. Japan Veterinary Biomarkers Market
  • 9.6.4. Australia Veterinary Biomarkers Market
  • 9.6.5. South Korea Veterinary Biomarkers Market
  • 9.6.6. Rest of Asia Pacific Veterinary Biomarkers Market
• 9.7. Latin America Veterinary Biomarkers Market Snapshot
  • 9.7.1. Brazil Veterinary Biomarkers Market
  • 9.7.2. Mexico Veterinary Biomarkers Market
• 9.8. Middle East & Africa Veterinary Biomarkers Market
  • 9.8.1. Saudi Arabia Veterinary Biomarkers Market
  • 9.8.2. South Africa Veterinary Biomarkers Market
  • 9.8.3. Rest of Middle East & Africa Veterinary Biomarkers Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Zoetis Services LLC
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Virbac
  • 10.3.3. Veterinary Biomarkers, Inc.
  • 10.3.4. ACUVET BIOTECH
  • 10.3.5. Merck & Co., Inc.
  • 10.3.6. IDEXX Laboratories, Inc.
  • 10.3.7. MI:RNA Diagnostics Ltd
  • 10.3.8. Mercodia AB
  • 10.3.9. Antech Diagnostics, Inc.
  • 10.3.10. Vimian Group

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption